# Novartis completes acquisition of MorphoSys, plans squeeze-out and delisting

Novartis completed its acquisition of MorphoSys in May 2024, holding approximately 91.04% of shares as of June 20, 2024. Novartis plans to squeeze out minority shareholders and delist MorphoSys, offering EUR 68.00 per share.

- Type: Acquisition
- Announced: 2024-06-20
- Where: Germany
- Status: completed
- Products: pharmaceuticals
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Novartis](https://endata.com/companies/32041.md) (acquirer)
- [MorphoSys](https://endata.com/companies/78158.md) (target)

## Sources

- [sparknewswire.com](https://sparknewswire.com/newsfeed/novartis-to-squeeze-out-morphosys-minority-shareholders-initiate-delisting/), 2024-06-20: "Novartis to Squeeze Out MorphoSys Minority Shareholders, Initiate Delisting"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.